tetano
Editor, Senior Moderator
Int J Clin Pract
. 2020 Sep 15;e13708.
doi: 10.1111/ijcp.13708. Online ahead of print.
SARS-COV-2 (COVID-19) has neurotropic and neuroinvasive properties
Gonzalo Flores[SUP] 1 [/SUP]
Affiliations
Abstract
Now, we know that the first report of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was in December 2019 in Wuhan, China. In January, the existence of a disease caused by a virus with respiratory tropism for humans was announced, and in February it was already named SARS-Cov-2. The World Health Organization (WHO) [SUP]1[/SUP] gave it the name of COVID-19, on February 11. One month later, WHO declared that the disease caused by this virus was already a pandemic (WHO, 2020) [SUP]1[/SUP] . The virus started in China, then affected other Asian countries such as Japan, South Korea, etc., and later spread to Europe, then America.
Keywords: ACE-2; COVID-19; brain stem; central nervous system; neuroinvasive activity; neurotropism propierties.
. 2020 Sep 15;e13708.
doi: 10.1111/ijcp.13708. Online ahead of print.
SARS-COV-2 (COVID-19) has neurotropic and neuroinvasive properties
Gonzalo Flores[SUP] 1 [/SUP]
Affiliations
- PMID: 32935417
- DOI: 10.1111/ijcp.13708
Abstract
Now, we know that the first report of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was in December 2019 in Wuhan, China. In January, the existence of a disease caused by a virus with respiratory tropism for humans was announced, and in February it was already named SARS-Cov-2. The World Health Organization (WHO) [SUP]1[/SUP] gave it the name of COVID-19, on February 11. One month later, WHO declared that the disease caused by this virus was already a pandemic (WHO, 2020) [SUP]1[/SUP] . The virus started in China, then affected other Asian countries such as Japan, South Korea, etc., and later spread to Europe, then America.
Keywords: ACE-2; COVID-19; brain stem; central nervous system; neuroinvasive activity; neurotropism propierties.